Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Bure Equity - sale of Parere AB to WM-data AB
Mandate

Bure Equity - sale of Parere AB to WM-data AB

May 12, 2005

In march 2004, the listed Swedish investment company Bure Equity AB, entered into an agreement to sell all the shares in the subsidiary Parere AB to WM-data AB for MSEK 325 (MEUR). The transfer was effected in april 2004 after the approval of the Swedish Competition Authority. Parere develops and provides software and services to help operations manage their human and structural capital efficiently. WM-data is a listed IT services company. Parere's annual turnover for 2003 amounted to MSEK 214 (MEUR 23,2).

Vinge acted for Bure Equity.
Torbjörn Sköld (responsible partner)
Magnus Pauli (associate)

Related

Vinge advises Morrow Bank AB (publ) in connection with the bank’s sale of parts of MedMera Bank and the sale of NPL portfolios

 Vinge has advised Morrow Bank AB (publ) in connection with the divestment of parts of MedMera Bank’s operations to a leading global credit investment firm. The divestment is structured as a sale of shares and priced at a premium of approximately SEK 90 million above equity value as per the completion date. The transaction includes parts of MedMera’s banking operations such as IT infrastructure, organisation and management, whilst Morrow Bank retains MedMera’s performing loans, deposits, customers, the MedMera brand, the Coop partnership agreement as well as key personnel.
September 15, 2026

Vinge advises HealthCap in conjunction with its investment in AMRA Medical

 HealthCap is investing in AMRA Medical AB, a company that analyses whole-body MRI images to classify and quantify an individual’s muscle and fat tissue throughout the body and places this in relation to human health and disease.
September 15, 2026

Vinge has advised EQT managed Scaleup Europe Fund on its investment in Tandem Health

 Vinge has advised EQT managed Scaleup Europe Fund as lead investor in Tandem Health's USD 100 million Series B investment round, with participation from existing investors Kinnevik, Northzone, Amino Collective and Visionaries. Tandem Health is an AI healthcare company founded in 2023 and headquartered in Sweden. Tandem Health operates as an AI partner within the healthcare sector across Europe, providing AI medical assistant support to clinicians in connection with patient visits.
September 15, 2026